Ongoing Clinical Trials Ongoing Clinical Trials

Ongoing Clinical Trials

Home >> Clinical Trial Guidance >> Ongoing Clinical Trials

We inform you of the clinical trials that are being conducted by K-MASTER Precision Medicine Project Group.

* Protocol No. KM-07
* Research Title A phase III, randomized, multi-center study to determine the efficacy of the intercalating combination treatment of chemotherapy and gefitinib or chemotherapy as adjuvant treatment in NSCLC with common EGFR mutations.
* Overall Research Director Cho Byoung-chul Affiliate Yonsei Cancer Center
Carcinoma Non-small cell lung cancer
Target Gene EGFR Clinical Trial Drug Gefitinib/Pemetrexed
Research period 2018.06.28 ~ 2021.12.31 Progress Status registering
Number of recipients 55 / 225 Registration rate 24.44%

Institutional research participation

No. Research manager Research institution

:: There is no registered research participant information. ::

prev list next

arrow Method of participation

If you want to participate in the clinical examination, please contact the email address below.

Email kmaster@korea.ac.kr | CONTACT Secretariat 02.2286.1564 | Clinical Trial Coordinating Center 02.2286.1562